title: Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
authors.affiliation: Service des Maladies du Sang, Hôpital Saint-Antoine, Paris.
authors.forename: J P
authors.initials: JP
authors.lastname: Laporte
authors.forename: F
authors.initials: F
authors.lastname: Isnard
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
authors.forename: M
authors.initials: M
authors.lastname: Woler
authors.forename: A
authors.initials: A
authors.lastname: Najman
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin